No articles available
January 07, 2008
Janice Sidorick was working in regulatory affairs for a pharmaceutical company that was starting up a cardiology trial. As Sidorick recalls, there were 250 sites with 500 patients in five countries. Most of the sites were in the U.S., Canada and Eastern Europe, with a smattering in South Africa. Twenty, to be exact. But when enrollment was finished, says Sidorick, the South African sites blew the rest out of the water. They had each enrolled between 80 and 100 patients, while the sites in other countries lagged far, far behind. Most recruited less than half of that. Often Overlooked The experience was eye-opening for Sidorick. Pivotal, even. In 2004, she launched the Newport Beach, CA-based contract research organization (CRO) Janix, a year later opening an office in Midrand, South Africa, outside Johannesburg, the country’s largest city and the home of the regulatory body that approves trials. Enrollment Rocks “Enrollment is amazing,”…more...